Trusted News from Afghanistan and Beyond

FDA advisory panel endorses Grail blood test for cancer, saying benefits outweigh risks - STAT

FDA advisory panel endorses Grail blood test for cancer, saying benefits outweigh risks - STAT
Business

Listen to this article

0%

A Food and Drug Administration advisory panel on Wednesday endorsed Galleri, a blood test designed by the biotech firm Grail to screen for multiple types of cancer, concluding that the benefits of th… [+694 chars]

Leave A Comment

Comments are moderated and may take time to appear.

Comments

No comments yet. Be the first to comment!

Stay Connected